Zyflamend reduces the expression of androgen receptor in a model of castrate-resistant prostate cancer. (Q39465959)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958043%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Zyflamend reduces the expression of androgen receptor in a model of castrate-resistant prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958043%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958043%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Michael F. McEntee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958043%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

E-Chu Huang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958043%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Seung Joon Baek

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958043%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

J Jason Collier

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958043%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Steven Minkin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958043%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

John Biggerstaff

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958043%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Jay Whelan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958043%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

29 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958043%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958043%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958043%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958043%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

1287-1296

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958043%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.606956

International trends and patterns of prostate cancer incidence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.606956

Mechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.606956

Gene expression analysis of gallium-resistant and gallium-sensitive lymphoma cells reveals a role for metal-responsive transcription factor-1, metallothionein-2A, and zinc transporter-1 in modulating the antineoplastic activity of gallium nitrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.606956

Zyflamend, a unique herbal preparation with nonselective COX inhibitory activity, induces apoptosis of prostate cancer cells that lack COX-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.606956

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.606956

Mechanisms underlying the development of androgen-independent prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.606956

The development of androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.606956

An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.606956

Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.606956

Modification of androgen receptor function by IGF-1 signaling implications in the mechanism of refractory prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.606956

Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.606956

Androgen receptor expression is associated with prostate cancer-specific survival in castrate patients with metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.606956

Implications of insulin-like growth factor-I for prostate cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.606956

Akt in prostate cancer: possible role in androgen-independence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.606956

Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.606956

Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.606956

AKT regulates androgen receptor-dependent growth and PSA expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.606956

Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2011.606956

10.1080/01635581.2011.606956

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958043%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference